VAERS reports by lot

Merck Pneumococcal lot S033516: VAERS reports

53 VAERS reports list lot S033516 as a Merck Pneumococcal vaccine, received between 2020-01-03 and 2022-12-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
53
Reports
4%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction5835%
Musculoskeletal2314%
General / Systemic (non-local)2314%
Allergic / Anaphylactic1710%
Cardiac / Cardiovascular127%
Dermatological (non-injection-site)127%
Neurological85%
Gastrointestinal64%
Respiratory42%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida7
California7
Pennsylvania6
Texas4
Ohio4
Georgia3
Maryland3
New York2
Puerto Rico2
North Carolina2
New Jersey2
Arizona2

Reports by month received

2020-012
2020-026
2020-035
2020-041
2020-055
2020-068
2020-0710
2020-085
2020-094
2020-103
2020-113
2022-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.